Prescott General Partners LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Prescott General Partners LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,664,961
+2.4%
568,2460.0%0.11%
+6.0%
Q2 2023$1,625,184
-7.4%
568,2460.0%0.10%
-28.1%
Q1 2023$1,755,880
+46.4%
568,2460.0%0.14%
+43.3%
Q4 2022$1,198,999
-35.3%
568,2460.0%0.10%
-33.1%
Q3 2022$1,852,000
+1.5%
568,2460.0%0.14%
+16.0%
Q2 2022$1,824,000
-58.7%
568,246
-9.1%
0.12%
-37.8%
Q1 2022$4,413,000
+660.9%
625,100
+681.4%
0.20%
+905.0%
Q4 2021$580,00080,0000.02%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders